bluebird bio

Biotechnology

bluebird bio develops gene therapies for severe genetic diseases using lentiviral vectors to deliver therapeutic genes. The company has approved therapies for beta-thalassemia and cerebral adrenoleukodystrophy. bluebird bio's work demonstrates both the promise and challenges of gene therapy, including manufacturing complexity and pricing.

The Biology of Business

Sign up to be notified when the book is available to order.

Notify Me